Significant Differences: A Detailed Explanation of Human Cryopreservation and Perfusion Surgery at Home and Abroad
Release time:
2024-12-13
Human cryopreservation is a forward-looking and challenging interdisciplinary research project in life sciences, aimed at preserving the human body through the combined study of cryomedicine, cryobiological engineering, biomaterials, and clinical medicine. The objective is to maintain the structural integrity of the human body and gradually explore the restoration of function in tissues, organs, and systems after rewarming.
Currently, only a few institutions globally can perform complete human cryopreservation surgeries, including Alcor, CI in the United States, and KrioRus in Russia. The Shandong Yinfeng Institute of Life Sciences is the only human cryopreservation center in Asia. While these institutions are committed to realizing this project, significant differences exist in specific techniques, such as perfusion surgery.
Perfusion Surgery: A Significant Difference
Perfusion surgery is of utmost importance in all stages of human cryopreservation. In this stage, the blood in the human body is replaced with a cryoprotectant.
Foreign Perfusion Surgery: Traditional Open Chest Method
In foreign countries where human cryopreservation started earlier, the traditional open chest method is typically used in perfusion surgery. This involves directly inserting the perfusion cannula into the heart to replace the blood with cryoprotectant. The traditional open chest surgery usually involves an incision of about 30 cm.
Domestic Perfusion Surgery: Minimally Invasive Double-Access Extracorporeal Circulation Perfusion Plan
As a latecomer, the Shandong Yinfeng Institute of Life Sciences has been continuously optimizing and innovating surgical methods. They have adopted an unprecedented minimally invasive double-access extracorporeal circulation perfusion plan, reducing the surgical incision to 3-5 cm. This surgical approach is commonly used in cardiac surgery. The surgical team is composed of experts from top-tier domestic hospitals, including clinical response experts, cardiac surgeons, anesthesiologists, extracorporeal circulation perfusionists, and related auxiliary staff.
Director Sun Wenyu, a cardiac surgeon, mentioned in a media interview: "The process of blood replacement involves fully substituting the blood in the body with cryoprotectant using advanced minimally invasive double-access extracorporeal circulation perfusion surgery. This avoids the open damage caused by chest operations, with extracorporeal circulation perfusion through arterial and venous incisions at the neck and groin. This ensures brain perfusion while also considering systemic circulation perfusion. The entire perfusion surgery is conducted on a low-temperature operating table, using life support systems combined with extracorporeal circulation cooling technology to achieve body cooling, blood replacement, and cryoprotectant perfusion."
Domestic Technology Upgrade: Applying ECMO Technology to Human Cryopreservation Surgery
Building on this, the Yinfeng Cryomedicine expert team continuously upgrades the perfusion technology, applying ECMO technology to human cryopreservation surgery. This pioneering approach uses right femoral artery and vein ECMO percutaneous cannulation to rapidly establish extracorporeal circulation. During surgery, there is drainage through the femoral artery, vein, and bilateral external jugular veins, connected to extracorporeal circulation equipment. Perfusion pressure is used to control drainage flow, further enhancing perfusion efficiency to maximize brain and body synchronized cooling.
Although there are significant differences in surgical methods between domestic and foreign institutions, all are committed to advancing human cryopreservation technology to a more mature and scientific stage. The continuous emergence of new technologies drives the improvement of human cryopreservation technology and injects new vitality and hope into the future of medical development. Medicine is boundless, and the pursuit of dreams never stops. With our collective efforts, hopefully, this "lighthouse project" will soon become a reality.
Latest developments
In January 2025, members of the Yinfeng cryomedicine team actively participated in the "Sino-French Aerial Emergency Medical Rescue Training" and obtained certification. This signifies a further enhancement of the team's professional capabilities in the field of international emergency medical rescue.
Brands are an important symbol of high-quality development. Under the drive of strategies such as Brand Strong Province and Good Products Shandong, Shandong brands have risen to prominence. Particularly in recent years, Shandong brands have focused on new quality productivity, using "new" to enhance quality, achieving remarkable results in high-quality development.
With infinite hope for future medical technology, I applied to become a member of the Yinfeng Life Extension Program and volunteered to contribute to cryobiology in a hundred years by becoming a cryonics volunteer. I also believe that preservation in China is safer.
As a distinguished emblem of technological innovation in Shandong, Yinfeng's Life Continuation Project will continue to build a bridge for domestic and international government research and academic exchange, continually strengthen scientific collaborations and result transformations with global research institutions, consistently contribute to the development of cryobiomedicine, and inject continuous hope into the shared ideal of extending human life.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
